BIPHASIX

DERMAL AND MUCOSAL DRUG DELIVERY SYSTEMS COMPRISED OF LIQUIDS, CREAMS AND GELS APPLIED TO THE SKIN OR MUCOSA AND CONTAINING PHARMACEUTICAL AGENTS ENCAPSULATED IN VESICLES UTILIZING A LIPID-BASED MICROENCAPSULATING PROCESS, FOR USE IN THE TREATMENT OF CARDIOLOGICAL DISEASES, DERMATOLOGICAL DISEASES, ENDOCRINE DISORDERS, GASTROINTESTINAL DISORDERS, HEMATOLOGICAL DISORDERS, BACTERIAL INFECTIOUS DISEASES, FUNGAL INFECTIOUS DISEASES, PARASITIC INFECTIOUS DISEASES, VIRAL INFECTIOUS DISEASES, MALIGNANT CANCER DISORDERS, METABOLIC DISEASES, NEUROLOGICAL DISORDERS, OPHTHALMOLOGY, DISORDERS, POISONING DISORDERS PSYCHIATRIC DISORDERS, PULMONARY DISORDERS, RENAL DISORDERS, RHEUMATOLOGICAL DISORDERS, NAUSEA, DIARRHEA, LOCAL PAIN, SYSTEMIC PAIN, OBESITY, ERECTILE DYSFUNCTION, SARCOIDOSIS, SLEEP DISORDERS AND PROVIDING VACCINE TREATMENTS